Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo

AIDS Research and Human Retroviruses

Volumn 20, Issue 8, 2004, Pages 871-884

  Villamide Herrera, L ^a   Ignatius, R ^b   Eller, M A ^c   Wilkinson, K ^c   Griffin, C ^c   Mehlhop, E ^d   Jones, J ^e   Han, S Y ^a   Lewis, M G ^f   Parrish, S ^c   Vancott, T C ^c   Lifson, J D ^g   Schlesinger, S ^h   Mascola, J R ⁱ   Pope, M ^a  

^a POPULATION COUNCIL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e University of Alabama at Birmingham   (United States)

^f BIOQUAL INC   (United States)

^g SAIC FREDERICK INC   (United States)

^h ROCKEFELLER UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; KEYHOLE LIMPET HEMOCYANIN; POL PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TETANUS TOXOID; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANARYPOX VIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IN VIVO STUDY; LEUKOCYTE MIGRATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACACA; MALE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CANARYPOX VIRUS; DENDRITIC CELLS; GENETIC VECTORS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 4344562851     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/0889222041725136     Document Type: Article

References (51)

1. Mascola JR: Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 2002;20:1922-1925.
2. Letvin NL, Barouch DH, and Montefiori DC: Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 2002;20:73-99.
3. Nabel GJ: HIV vaccine strategies. Vaccine 2002;20:1945-1947.
4. Ho DD and Huang Y: The HIV-1 vaccine race. Cell 2002;110:135-138.
5. Gaschen B, Taylor J, Yusim K, et al.: Diversity considerations in HIV-1 vaccine selection. Science 2002;296:2354-2360.
6. McMichael A and Hanke T: The quest for an AIDS vaccine: Is the CD8+ T-cell approach feasible? Nat Rev Immunol 2002;2:283-291.
7. Peters BS: The basis for HIV immunotherapeutic vaccines. Vaccine 2002;20:688-705.
8. Mascola JR: Defining the protective antibody response for HIV-1. Curr Mol Med 2003;3:209-216.
9. Kalams SA: Cellular immunity for prevention and clearance of HIV infection. Curr Mol Med 2003;3:195-208.
10. Desrosiers RC: Non-human primate models for AIDS vaccines. AIDS 1995;9:S137-141.
11. Kozlowski PA and Neutra MR: The role of mucosal immunity in prevention of HIV transmission. Curr Mol Med 2003;3:217-228.
12. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
13. Banchereau J, Briere F, Caux C, et al.: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
14. Banchereau J, Schuler-Thurner B, Palucka AK, and Schuler G: Dendritic cells as vectors for therapy. Cell 2001;106:271-274.
15. Steinman RM and Pope M: Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 2002;109:1519-1526.
16. Pope M: Dendritic cells as a conduit to improve HIV vaccines. Curr Mol Med 2003;3:229-242.
17. Lu W, Wu X, Lu Y, Guo W, and Andrieu JM: Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 2002;9:27-32.
18. O'Doherty U, Ignatius R, Bhardwaj N, and Pope M: Generation of monocyte-derived cells from the precursors in rhesus macaque blood. J Immunol Methods 1997;207:185-194.
19. Pope M, Elmore D, Ho D, and Marx P: Dendritic cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV. AIDS Res Hum Retroviruses 1997;13:819-827.
20. Hu J, Pope M, O'Doherty U, Brown C, and Miller CJ: Immunophenotypic characterization of SIV-infected cells in cervix, vagina and draining lymph nodes of chronically infected rhesus macaques. Lab Invest 1998;78:435-451.
21. Ignatius R, Isdell F, O'Doherty U, and Pope M: Dendritic cells from skin and blood of macaques both promote SIV replication with T cells from different anatomical sites. J Med Primatol 1998;27:121-128.
22. Hu J, Miller CJ, O'Doherty U, Marx PA, and Pope M: The dendritic cell-T cell milieu of the lymphoid tissue of the tonsil provides a locale in which SIV can reside and propagate at chronic stages of infection. AIDS Res Hum Retroviruses 1999;15:1305-1314.
23. Barratt-Boyes SM, Zimmer MI, Harshyne LA, et al.: Maturation and trafficking of monocyte-derived dendritic cells in monkeys: Implications for dendritic cell-based vaccines. J Immunol 2000;164:2487-2495.
24. Mehlhop ER, Villamide LA, Frank I, et al.: Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J Immunol Methods 2002;260:219-234.
25. Pichyangkul S, Saengkrai P, Yongvanitchit K, et al.: Isolation and characterization of rhesus blood dendritic cells using flow cytometry. J Immunol Methods 2001;252:15-23.
26. Frank I, Santos JJ, Mehlhop E, et al.: Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4+ and CD8+ T cell responses. J AIDS 2003;34:7-19.
27. Coates PT, Barratt-Boyes SM, Zhang L, et al.: Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 2003;102:2513-2521.
28. Steinman RM and Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99:351-358.
29. Bonifaz L, Bonnyay D, Mahnke K, et al.: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J Exp Med 2002;196:1627-1638.
30. Trombetta ES, Ebersold M, Garrett W, Pypaert M, and Mellman I: Activation of lysosomal function during dendritic cell maturation. Science 2003;299:1400-1403.
31. Voltan R and Robert-Guroff M: Live recombinant vectors for AIDS vaccine development. Curr Mol Med 2003;3:273-284.
32. Ignatius R. Marovich M, Mehlhop E, et al.: Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor-α secretion. J Virol 2000;74:11329-11338.
33. Engelmayer J, Larsson M, Lee A, et al.: Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency viras CD8+ and CD4+ T cell responses from chronically infected individuals. J Virol 2001;75:2142-2153.
34. Marovich MA, Mascola JR, Eller MA, et al.: Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. J Infect Dis 2002;186:1242-1252.
35. Arthur LO, Bess JW Jr, Chertova EN, et al.: Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: A candidate SFV vaccine. AIDS Res Hum Retroviruses 1998;14(Suppl. 3):S311-319.
36. Rossio JL, Esser MT, Suryanarayana K, et al.: Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 1998;72:7992-8001.
37. Frank I, Piatak MJ, Stoessel H, et al.: Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): Differential intracellular fate of virions in mature and immature DCs. J Virol 2002;76:2936-2951.
38. + memory T cells. J Exp Med 1997;186:859-865.
39. Larsson M, Jin X, Ramratnam B, et al.: A recombinant vaccinia virus based ELISPOT assay detects high frequencies of pol specific CD8+ T cells in chronically infected HIV-1 positive individuals. AIDS 1999;13:767-777.
40. Jonuleit H, Schmitt E, Schuler G, Knop J, and Enk AH: Induction of human IL-10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells. J Exp Med 2000;192:1213-1222.
41. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, and Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233-238.
42. Dhodapkar MV and Steinman RM: Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002;100:174-177.
43. Dhodapkar MV, Krasovsky J, Steinman RM, and Bhardwaj N: Mature dendritic cells boost functionally superior T cells in humans without foreign helper epitopes. J Clin Invest 2000;105:R9-R14.
44. Albert ML, Sauter B, and Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
45. Motta I, Andre F, Lim A, et al.: Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canary-pox virus-infected dendritic cells. J Immunol 2001;167:1795-1802.
46. + and CD4+ T cells: Helper role of CD8+ T cells in the development of T helper type 1 responses. J Exp Med 2002;195:473-483.
47. Berberich C, Ramirez-Pineda JR, Hambrecht C, et al.: Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol 2003;170:3171-3179.
48. Zhu Y, Koo K, Bradshaw JD, et al.: Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses. J Med Primatol 2000;29:182-192.
49. + T cells and monocytes elicited by immunization of rhesus monkeys with antigen-pulsed dendritic cells control SIV replication. AIDS Res Hum Retroviruses 2002;18:143-148.
50. Guerkov RE, Targoni OS, Kreher CR, et al.: Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: Cognate vs. nonspecific production of the cytokine. J Immunol Methods 2003;279:111-121.
51. Pope M and Haase AT: Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003; 9:847-852.